⌕
CRISPR Therapeutics· CRSP · NasdaqHeld by 77 US ETFsOpen stock report

ETFs That Hold CRISPR Therapeutics (CRSP)

Like CRISPR Therapeutics but not the single-stock risk? Find every fund that holds it, ranked by how much. Flip the lens to find the cleanest way to own it, the most diversified wrapper, or (in avoidance mode) which of your funds sneak it in.

Lens
the cleanest, most concentrated way to own it
Embeds on the CRSP stock report“ETF Exposure” card · top 5 by weight
ARKG
5.3%
CRSP weight
ARKK
4.3%
CRSP weight
NXTE
3.2%
CRSP weight
GNOM
2.6%
CRSP weight
MEDX
2.4%
CRSP weight
Issuer
FundIssuerCRSP weight · shared scaleExpenseAUM
ARKG
ARK Genomic Revolution ETF
ARK
5.3%
0.75%$2.2B›
ARKK
ARK Innovation ETF
ARK
4.3%
0.75%$7.9B›
NXTE
AXS Green Alpha ETF
AXS Investments
3.2%
1.00%$47.3M›
GNOM
Global X Genomics & Biotechnology ETF
Global X
2.6%
0.50%$106.1M›
MEDX
Horizon Kinetics Medical ETF
Horizon Kinetics
2.4%
0.85%$17.2M›
The remaining 72 funds holding CRSP are available on a paid plan.Premium · $119/yr · 7-day trial · cancel anytimeUnlock every holder →
77 US-listed holders · fee and assets from the nightly fund profilePage 1 / 1

Reverse lookup across 360 global listings · ranked by portfolio weight. Weights are the latest holdings each fund reported, refreshed in the background, so the weights and the holder, issuer and listing counts this page prints can all shift between two loads. Fee and assets are joined for every holder from the nightly fund profile, not read live. Exposure data is decision-support, not a recommendation · Not investment advice.

How many ETFs hold CRISPR Therapeutics (CRSP)?

CRISPR Therapeutics (CRSP) is held by 77 US-listed ETFs, in each fund's latest reported holdings.

Which ETF holds the most CRISPR Therapeutics?

Of the US-listed ETFs in our fund data, ARK Genomic Revolution ETF (ARKG) holds CRISPR Therapeutics at the largest portfolio weight, in each fund's latest reported holdings.

What ETFs hold CRISPR Therapeutics?

By portfolio weight, the US-listed ETFs that hold the most CRISPR Therapeutics are ARKG, ARKK, NXTE, GNOM and MEDX, among others, in each fund's latest reported holdings.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.